Interní Med. 2018; 20(1): 27-31 | DOI: 10.36290/int.2018.006

Antibiotic treatment of infections caused by atypical bacteria

prof. MUDr. Milan Kolář, Ph.D.
Ústav mikrobiologie LF UP v Olomouci

The presented paper describes atypical bacteria clinically significant in the conditions of the Czech Republic. It characterizes themost common diseases caused by these bacteria, their microbiological diagnostics and the possibilities of antibiotic treatment.

Keywords: chlamydia/chlamydophila, mycoplasma, ureaplasma, borrelia, legionella, treponema, leptospira, infections, therapy

Published: March 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolář M. Antibiotic treatment of infections caused by atypical bacteria. Interní Med. 2018;20(1):27-31. doi: 10.36290/int.2018.006.
Download citation

References

  1. Neu HC. The crisis in antibiotic resistance. Science 1992; 257: 1064-1073. Go to original source... Go to PubMed...
  2. Kolář M. Stoupající odolnost bakterií k antibiotikům - výzva pro farmakoterapii 21. století. Acta Med 2012; 6: 9-12.
  3. Kolář M, Látal T, Čermák P. Klinicko-mikrobiologické podklady racionální antibiotické léčby. Trios, 2002.
  4. Kolář M. Respirační infekce a jejich léčba. Maxdorf Jessenius, 2016.
  5. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150: 1545-1549. Go to original source... Go to PubMed...
  6. Tumbarello M, Sanguinetti M, Montuori E, et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-ß-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 2007; 51: 1987-1994. Go to original source... Go to PubMed...
  7. Herkel T, Uvizl R, Adamus M, et al. Epidemiology of hospital-acquired pneumonia: Results of a Central European multicenter, prospective, observational study compared with data from the European region. Biomed Pap 2016; 160: 448-455. Go to original source... Go to PubMed...
  8. Votava M, a kol. Lékařská mikrobiologie speciální. Neptun, 2003.
  9. Kolek V, Bartoš V, Fojtů H, et al. Studie PAP - Pneumonie v ambulantní péči. Stud Pneumol Phtiseol 2007; 67: 146-155.
  10. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J 2002; 20: 20-27. Go to original source... Go to PubMed...
  11. Beneš J, a kol. Infekční lékařství. Galén, 2009.
  12. Blaser MJ. Mizející mikroby. Slovart, 2015.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.